Hematology
Matthew Rettig, MD
Medical Director, Prostate Cancer Program of the Institute of Urologic Oncology at UCLA; Chief of Hematology-Oncology, VA Medical Center in Greater Los Angeles; Professor of Medicine and Urology, David Geffen School of Medicine at UCLA
Dr. Matthew B. Rettig is a medical oncologist specializing in genitourinary malignancies, with a primary clinical focus on advanced prostate cancer. He serves as Medical Director of the Prostate Cancer Program at the Institute of Urologic Oncology at UCLA and Chief of Hematology-Oncology at the VA Medical Center in Greater Los Angeles. Dr. Rettig treats conditions including prostate cancer, thyroid cancer, bone cancer, and clear cell renal cell carcinoma, treating prostate cancer, thyroid cancer
35+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine), 1998
Education & Training
- MD, Duke University School of Medicine, 1990
- Internship Internal Medicine, LAC + USC Medical Center, 1991
- Residency Internal Medicine, University of Washington School of Medicine, 1993
- Fellowship Internal Medicine, UCLA School of Medicine: Internal Medicine, 1996
Peer Recognition
- Los Angeles Magazine — Top Doctors
2018
- Super Doctors — Super Doctor
2018, 2024-2025 (3 years)
Recognition & Leadership
Awards & Honors
- American Society of Hematology Scholar Award
- Advanced Career Development Award, Department of Veterans Affairs
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Ronald Reagan UCLA Medical Center
- Santa Monica UCLA Medical Center and Orthopaedic Hospital
Languages
English
Experience
35+ years in practice